Dose Fractionation of Moxifloxacin for Treatment of Tuberculosis: Impact of Dosing Interval and Elimination Half-Life on Microbial Kill and Resistance Suppression
Drusano, G L, Rogers, Stephanie, Brown, David, Peloquin, C A, Neely, Michael, Yamada, Walter, Kim, Sarah, Almoslem, Mohammed, Schmidt, Stephan, Louie, Arnold
Published in Antimicrobial agents and chemotherapy (18.03.2021)
Published in Antimicrobial agents and chemotherapy (18.03.2021)
Get full text
Journal Article
The Funnel: a Screening Technique for Identifying Optimal Two-Drug Combination Chemotherapy Regimens
Drusano, G L, Kim, Sarah, Almoslem, Mohammed, Schmidt, Stephan, D'Argenio, D Z, Myrick, Jenny, Duncanson, Brandon, Nole, Jocelyn, Brown, David, Peloquin, C A, Neely, Michael, Yamada, Walter, Louie, Arnold
Published in Antimicrobial agents and chemotherapy (20.01.2021)
Published in Antimicrobial agents and chemotherapy (20.01.2021)
Get full text
Journal Article
Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis
Peloquin, C A, Velásquez, G E, Lecca, L, Calderón, R I, Coit, J, Milstein, M, Osso, E, Jimenez, J, Tintaya, K, Sanchez Garavito, E, Vargas Vasquez, D, Mitnick, C D, Davies, G
Published in Antimicrobial agents and chemotherapy (01.08.2017)
Published in Antimicrobial agents and chemotherapy (01.08.2017)
Get full text
Journal Article
Optimizing the clinical pharmacology of tuberculosis medications
Egelund, E F, Alsultan, A, Peloquin, C A
Published in Clinical pharmacology and therapeutics (01.10.2015)
Published in Clinical pharmacology and therapeutics (01.10.2015)
Get more information
Journal Article
Developing New Drugs for Mycobacterium tuberculosis Therapy: What Information Do We Get from Preclinical Animal Models?
Drusano, G L, Duncanson, Brandon, Scanga, C A, Kim, S, Schmidt, S, Neely, M N, Yamada, W M, Vicchiarelli, Michael, Peloquin, C A, Louie, Arnold
Published in Antimicrobial agents and chemotherapy (17.11.2020)
Published in Antimicrobial agents and chemotherapy (17.11.2020)
Get full text
Journal Article
Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure–response relations from two phase II clinical trials
Savic, RM, Weiner, M, MacKenzie, WR, Engle, M, Whitworth, WC, Johnson, JL, Nsubuga, P, Nahid, P, Nguyen, NV, Peloquin, CA, Dooley, KE, Dorman, SE
Published in Clinical pharmacology and therapeutics (01.08.2017)
Published in Clinical pharmacology and therapeutics (01.08.2017)
Get full text
Journal Article
Vitamin D, race, and experimental pain sensitivity in older adults with knee osteoarthritis
Glover, T. L., Goodin, B. R., Horgas, A. L., Kindler, L. L., King, C. D., Sibille, K. T., Peloquin, C. A., Riley III, J. L., Staud, R., Bradley, L. A., Fillingim, R. B.
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.12.2012)
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.12.2012)
Get full text
Journal Article
Management of patients with multidrug-resistant tuberculosis
Lange, C., Aarnoutse, R. E., Alffenaar, J. W. C., Bothamley, G., Brinkmann, F., Costa, J., Chesov, D., van Crevel, R., Dedicoat, M., Dominguez, J., Duarte, R., Grobbel, H. P., Günther, G., Guglielmetti, L., Heyckendorf, J., Kay, A. W., Kirakosyan, O., Kirk, O., Koczulla, R. A., Kudriashov, G. G., Kuksa, L., van Leth, F., Magis-Escurra, C., Mandalakas, A. M., Molina-Moya, B., Peloquin, C. A., Reimann, M., Rumetshofer, R., Schaaf, H. S., Schön, T., Tiberi, S., Valda, J., Yablonskii, P. K., Dheda, K.
Published in The international journal of tuberculosis and lung disease (01.06.2019)
Published in The international journal of tuberculosis and lung disease (01.06.2019)
Get full text
Journal Article
Therapeutic drug monitoring for isoniazid and rifampicin exposure
Peloquin, C. A.
Published in The international journal of tuberculosis and lung disease (01.03.2024)
Published in The international journal of tuberculosis and lung disease (01.03.2024)
Get full text
Journal Article
Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis
JOHNSON, J. L, HADAD, D. J, PALACI, M, DIETZE, R, BOOM, W. H, DALEY, C. L, PELOQUIN, C. A, EISENACH, K. D, JANKUS, D. D, DEBANNE, S. M, CHARLEBOIS, E. D, MACIEL, E
Published in The international journal of tuberculosis and lung disease (01.06.2006)
Get full text
Published in The international journal of tuberculosis and lung disease (01.06.2006)
Journal Article
Administration and monitoring of clofazimine for NTM infections in children with and without cystic fibrosis
Cameron, LH, Peloquin, CA, Hiatt, P, Mann, M, Starke, JR, Faircloth, J, McNeil, JC, Patel, A, Ruiz, F
Published in Journal of cystic fibrosis (01.03.2022)
Published in Journal of cystic fibrosis (01.03.2022)
Get full text
Journal Article
Perspectives for personalized therapy for patients with multidrug‐resistant tuberculosis
Lange, C., Alghamdi, W. A., Al‐Shaer, M. H., Brighenti, S., Diacon, A. H., DiNardo, A. R., Grobbel, H. P., Gröschel, M. I., Groote‐Bidlingmaier, F., Hauptmann, M., Heyckendorf, J., Köhler, N., Kohl, T. A., Merker, M., Niemann, S., Peloquin, C. A., Reimann, M., Schaible, U. E., Schaub, D., Schleusener, V., Thye, T., Schön, T.
Published in Journal of internal medicine (01.08.2018)
Published in Journal of internal medicine (01.08.2018)
Get full text
Journal Article
Erratum for Peloquin et al., "Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis"
Peloquin, C A, Velásquez, G E, Lecca, L, Calderón, R I, Coit, J, Milstein, M, Osso, E, Jimenez, J, Tintaya, K, Garavito, E Sanchez, Vasquez, D Vargas, Mitnick, C D, Davies, G
Published in Antimicrobial agents and chemotherapy (01.09.2017)
Published in Antimicrobial agents and chemotherapy (01.09.2017)
Get full text
Journal Article
pharmacokinetics of a single oral or rectal dose of concurrently administered isoniazid, rifampin, pyrazinamide, and ethambutol in Asian elephants (Elephas maximus)
P. Brock, A, Isaza, R, Egelund, E. F, Hunter, R. P, Peloquin, C. A
Published in Journal of veterinary pharmacology and therapeutics (01.10.2014)
Published in Journal of veterinary pharmacology and therapeutics (01.10.2014)
Get full text
Journal Article
Aminoglycoside Toxicity: Daily versus Thrice-Weekly Dosing for Treatment of Mycobacterial Diseases
Peloquin, Charles A., Berning, Shaun E., Nitta, Annette T., Simone, Patricia M., Goble, Marian, Huitt, Gwen A., Iseman, Michael D., Cook, James L., Curran-Everett, Douglas
Published in Clinical infectious diseases (01.06.2004)
Published in Clinical infectious diseases (01.06.2004)
Get full text
Journal Article
Population pharmacokinetic modeling of isoniazid, rifampin, and pyrazinamide
PELOQUIN, C. A, JARESKO, G. S, YONG, C.-L, KEUNG, A. C. F, BULPITT, A. E, JELLIFFE, R. W
Published in Antimicrobial Agents and Chemotherapy (01.12.1997)
Published in Antimicrobial Agents and Chemotherapy (01.12.1997)
Get full text
Journal Article
Clinical Outcomes Among Patients With Drug-resistant Tuberculosis Receiving Bedaquiline- or Delamanid-Containing Regimens
Kempker, R R, Mikiashvili, L, Zhao, Y, Benkeser, D, Barbakadze, K, Bablishvili, N, Avaliani, Z, Peloquin, C A, Blumberg, H M, Kipiani, M
Published in Clinical infectious diseases (03.12.2020)
Published in Clinical infectious diseases (03.12.2020)
Get full text
Journal Article
Therapeutic drug monitoring and TB treatment outcomes in patients with diabetes mellitus
Alkabab, Y., Warkentin, J., Cummins, J., Katz, B., Denison, B. M., Bartok, A., Khalil, A., Young, L. R., Timme, E., Peloquin, C. A., Ashkin, D., Houpt, E. R., Heysell, S. K.
Published in The international journal of tuberculosis and lung disease (01.02.2023)
Published in The international journal of tuberculosis and lung disease (01.02.2023)
Get full text
Journal Article